NBTY President Adopts Rule 10b5-1 Trading Plan
07 Agosto 2007 - 11:30PM
PR Newswire (US)
BOHEMIA, N.Y., Aug. 7 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY), (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced that its
President and Chief Financial Officer, Harvey Kamil, has adopted a
prearranged stock trading plan to sell a portion of his company
stock over time as part of his individual long-term strategy for
asset diversification and liquidity. The stock trading plan was
adopted in accordance with Rule 10b5-1 of the U.S. Securities
Exchange Act of 1934 and NBTY's policies with respect to insider
sales. Rule 10b5-1 allows corporate officers and directors to adopt
written, pre-arranged stock trading plans when they do not have
material, non-public information. Using these plans, insiders can
gradually diversify their investment portfolios, can spread stock
trades out over an extended period of time to reduce any market
impact and can avoid concerns about whether they had material,
non-public information when they sold their stock. Under his Rule
10b5-1 plan, which was effective as of August 6, 2007, Mr. Kamil
may sell up to 818,285 shares of NBTY stock (including shares to be
issued upon Mr. Kamil's stock option exercise) over a period of
approximately two years. The plan allows up to 200,000 shares of
NBTY stock to be sold per month, starting from February 2008 until
February 2010, subject to certain price restrictions. If the target
prices are achieved and all stock eligible for sale under the plan
is sold, Mr. Kamil will still own approximately 1% of NBTY's
current outstanding stock. ABOUT NBTY NBTY is a leading global
vertically integrated manufacturer, marketer and distributor of a
broad line of high-quality, value-priced nutritional supplements in
the United States and throughout the world. Under a number of NBTY
and third party brands, the Company offers over 22,000 products,
including products marketed by the Company's Nature's Bounty(R)
(http://www.naturesbounty.com/), Vitamin World(R)
(http://www.vitaminworld.com/), Puritan's Pride(R)
(http://www.puritan.com/), Holland & Barrett(R)
(http://www.hollandandbarrett.com/), Rexall(R)
(http://www.rexallsundown.com/), Sundown(R)
(http://www.rexallsundown.com/), MET-Rx(R) (http://www.metrx.com/),
WORLDWIDE Sport Nutrition(R) (http://www.sportnutrition.com/),
American Health(R) (http://www.americanhealthus.com/), GNC (UK)(R)
(http://www.gnc.co.uk/), DeTuinen(R) (http://www.detuinen.nl/),
LeNaturiste(TM) (http://www.lenaturiste.com/), SISU(R)
(http://www.sisu.com/), Osteo Bi-Flex(R)
(http://www.osteobiflex.com/), PureProtein(R)
(http://www.pureprotein.net/), Solgar(R) (http://www.solgar.com/)
and Ester-C(R) (http://www.ester-c.com/) brands. Contact: Harvey
Kamil Carl Hymans NBTY, Inc. G.S. Schwartz & Co. President
& Chief Financial Officer 212-725-4500 631-200-2020 DATASOURCE:
NBTY, INC. CONTACT: Harvey Kamil, President & Chief Financial
Officer of NBTY, Inc., +1-631-200-2020; or Carl Hymans, of G.S.
Schwartz & Co., +1-212-725-4500, Web site: http://www.nbty.com/
Copyright
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Lug 2023 a Lug 2024